Long-Circulating Nanobody Confers Durable Prophylaxis against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Infection.

Meanwhile, the Nanosota-3A-Fc-treated mice had 3.5-fold less viral titers than the untreated control mice, although the difference did not reach statistical significance ( p = 0.41).

also in 111,027 other papers